Richard Ransohoff
InvestorVenture Partner at Third Rock Ventures
East Coast
Writes $100K – $5M checks · typically $1.5M
Find your path to Richard
163 people in our graph share verified history with Richard — schools, employers, funds. One of them is your warm intro.
Lisa PurcellunlockedRichard: together at Third Rock Ventures (2024–2026)
×9Richard: together at Third Rock Ventures
Richard: together at Bard College
Richard: together at Cleveland Clinic
About
Richard Ransohoff is a neurologist who serves as a Venture Partner at Third Rock Ventures, where he focuses on neuroinflammation research and development opportunities. He joined the firm in 2018 from Biogen, and before that spent 30 years at the Cleveland Clinic, where he founded and directed the Neuroinflammation Research Center within the Lerner Research Institute. Trained as a neurologist, he cites a formative moment early in his career — a snowbound day when his clinic was still packed with patients — as a lasting motivation for his work in biotech.
Beyond investing
- Founded
- Founded and directed the Neuroinflammation Research Center in the Lerner Research Institute at the Cleveland Clinic.
- Education
- Earned a B.A. in Languages and Literature from Bard College. Earned an M.D. from Case Western Reserve University School of Medicine.
- More
- His office is located near the kitchen and he keeps track of where the peanut butter is.
From Richard's own website — common ground for a warm intro.
Experience
- American Brain FoundationBoard Membercurrent2026 — present
- Third Rock VenturesVenture Partnercurrent2019 — presentBoston, Massachusetts
- Third Rock VenturesEntrepreneur In Residence2018 — 2019Boston
- Abata TherapeuticsCo-founder and Chief Medical Officercurrent2021 — presentCambridge, Massachusetts, United States
- BiogenVP2014 — 2017
- Lerner Research Institute, Cleveland ClinicMember Of Scientific Staff1989 — 2014Cleveland/Akron, Ohio Area
- Cleveland ClinicNeurologist1984 — 2014Cleveland/Akron, Ohio Area
Skills & more
Chemokine biology7Blood-brain barrier7Neuroscience18Neurodegenerative disease9Multiple sclerosis10Cell Culture3
- neurology — American Board of Psychiatry and Neurology, Inc.
- Internal Medicine — American Board of Internal Medicine
From Richard's professional profile.
Investments
Investor
Abata Therapeutics
Per curated public sources.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Frequently asked questions
- Who is Richard Ransohoff?
- Richard Ransohoff is a neurologist who serves as a Venture Partner at Third Rock Ventures, where he focuses on neuroinflammation research and development opportunities. He joined the firm in 2018 from Biogen, and before that spent 30 years at the Cleveland Clinic, where he founded and directed the Neuroinflammation Research Center within the Lerner Research Institute. Trained as a neurologist, he cites a formative moment early in his career — a snowbound day when his clinic was still packed with patients — as a lasting motivation for his work in biotech.
- Where does Richard Ransohoff work?
- Richard Ransohoff is Venture Partner at Third Rock Ventures.
- What check size does Richard Ransohoff write?
- Richard Ransohoff typically writes checks of $100K – $5M.
- What companies has Richard Ransohoff invested in?
- Investments tracked here include Abata Therapeutics.
- Where did Richard Ransohoff go to school?
- Richard Ransohoff studied at Case Western Reserve University School of Medicine (Doctor of Medicine - MD, Medicine); Bard College (Bachelor of Arts - BA, Literature).
Same school
Also attended Case Western Reserve University School of Medicine22
Todd PonskyChief Innovation Officer at Flare Capital PartnersTarek El-SawyVenture Partner at RaivenGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresKingsley R. ChinManaging Partner at KIC VenturesSteven SchachterAdvisor, Medtech at Iaso VenturesGuy Fish, MDStrategic Advisor at Fletcher Spaght, Inc.
+ 16 more
Also attended Bard College16
Mischa VaughnHead of Content at Felicis VenturesNyheir HayesClient Experience Manager at The Innovation SpaceClaudio Martínez ToqueroInvestment Director at ASIF VenturesNolan EnglishHead of Platform at Prime Impact FundGarrett BrownSenior Associate at Revelation PartnersHannah BronfmanGeneral Partner at Conteur Capital Partners
+ 10 more
Shared employers
Also worked at Third Rock Ventures92
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 86 more
Also worked at Abata Therapeutics6
Danielle AbdelahadInvestor at Third Rock VenturesDavid KaufmanInvestor at Third Rock VenturesJefte DrijversInvestor at Third Rock VenturesJohn TrzupekManaging Director at Bain Capital Life SciencesNagesh MahanthappaExecutive Officer, Director at Scholar RockLorence KimGeneral Partner at Ascenta Capital
Also worked at Biogen98
Jigar RaythathaInvestor at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityJohn McCabePortfolio Company CFO & COO at Longwood FundChristina NeoAssociate at Asia Partners
+ 92 more
Also worked at Cleveland Clinic58
Kenneth Morand, Ph.D.Life Sciences Partner at CincyTechKenneth MorandLife Sciences Partner at CincyTechAndy RobbinsAnalyst at Miami University Redhawk VenturesDavid AllisonManaging Director at Westlake Village BioPartnersMarcie ReillyChief Growth Officer at The Innovation SpaceAkhil SaklechaAdvisor - Healthtech at Augment Ventures
+ 52 more